AN ACT concerning the state board of pharmacy; relating to emergency opioid antagonists; exempting law enforcement agencies who do not provide emergency opioid antagonist pursuant to the statewide protocol from the requirement to procure a physician medical director; amending K.S.A. 2024 Supp. 65-16,127 and repealing the existing section.